ALFA Finder
23:38 IST
NSE
Earnings Call
Amrutanjan Health Care Investor Presentation: Key Takeaways
Q2 FY27 net sales ₹135.2 Cr (+14.9%), PAT ₹17.3 Cr (+23.8%). H1 PAT ₹21.7 Cr, down 2.8% on cost pressure.
Amrutanjan Health Care Ltd
- Share price
- ₹520.15
- Market cap
- ₹1,504 Cr
- Revenue (annual)
- ₹502.6 Cr
- Net profit (annual)
- ₹57.92 Cr
- P/E (TTM)
- 26.2×Sector 43.8×
- Promoter holding
- 46.52%+0.00% QoQ
- FII holding
- 3.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 1Financial Results 1Earnings Call 1Dividend 1Board Meeting Date 1Annual General Meeting 1
Time
6 announcements with these filters
18:24 IST
NSE
Dividend
Amrutanjan Health Care Dividend
Amrutanjan Health Care set November 7, 2026 as the record date for its first FY2026-27 interim dividend. The dividend amount per share is not stated.
18:12 IST
NSE
Financial Results
Amrutanjan Health Care Q2 FY27 Results: Net Profit ₹17.3 Cr, Up 23.6% YoY
Amrutanjan Health Care Ltd reported revenue from operations of ₹135.2 Cr (+14.9% YoY) and net profit of ₹17.3 Cr (+23.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹17.3 Cr · +23.6% YoY
15:46 IST
BSE
Board Meeting Date
Amrutanjan Health Care Board Meeting Date
Amrutanjan Health Care scheduled its board meeting for 3 Nov 2026 to consider Q2/H1 results and 1st interim dividend. No financial figures or dividend amount are stated in this advance intimation.
11:37 IST
NSE
Other Announcement
Amrutanjan Health Care Other Announcement
Amrutanjan Health Care received a voluntary CRISIL ESG rating of 'Adequate' (score 60). No capital or operational impact arises from this rating.
17:04 IST
NSE
Annual General Meeting
Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited held its 89th AGM on September 23, 2026. The meeting transacted business including the adoption of accounts, dividend declaration, and director re-appointment.